Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Green tea extract ointment to prevent recurrence of external genital warts after ablation
ISRCTN44037479Phase 4Completed
- Sponsor
- Cantabria Labs
- Start
- Aug 2017
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of sinecatechins in anogenital warts (2 arms), sponsored by Cantabria Labs. Primary endpoint: Recurrence of new external genital warts. Started Aug 2017; status: completed.
02
Drugs
sinecatechins
03
Conditions
anogenital warts
Beyond the preview
Go deeper on ISRCTN44037479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN44037479.